One_CD of_IN the_DT viral_JJ proteins_NNS involved_VBN in_IN this_DT process_NN might_MD be_VB the_DT Tat_NN protein_NN ._.
Glucocorticoids_NNS GCS_NNS profoundly_RB inhibit_VBP several_JJ aspects_NNS of_IN T_NN cell_NN immunity_NN largely_RB through_IN inhibition_NN of_IN cytokine_NN expression_NN at_IN the_DT transcriptional_JJ and_CC posttranscriptional_JJ levels_NNS ._.
In_IN addition_NN ,_, an_DT inhibitor_NN of_IN PKC_NN blocked_VBD both_CC activated_VBD ras_NN and_CC phorbol_NN ester_NN stimulation_NN ,_, suggesting_VBG a_DT role_NN for_IN ras_NN upstream_JJ of_IN PKC_NN ._.
IL-2_NN induced_VBD less_RBR STAT1_NN alpha_NN activation_NN and_CC IFN-alpha_NN induced_VBD greater_JJR STAT5_NN activation_NN in_IN NK3.3_NN cells_NNS compared_VBN with_IN preactivated_JJ primary_JJ NK_NN cells_NNS ._.
Some_DT criteria_NNS which_WDT can_MD be_VB used_VBN to_TO define_VB steroid-resistant_JJ bronchial_JJ asthma_NN are_VBP listed_VBN here_RB ._.
Exposing_VBG human_JJ umbilical_JJ vein_NN endothelial_JJ cells_NNS HUVECs_NNS to_TO results_VBZ in_IN an_DT increase_NN in_IN polymorphonuclear_JJ leukocyte_NN PMN_NN adhesion_NN to_TO HUVECs_NNS ._.
Overexpression_NN of_IN full-length_JJ SCL_NN protein_NN in_IN the_DT lymphoid_JJ cell_NN lines_NNS ,_, SupT1_NN and_CC Raji_NN ,_, did_VBD not_RB alter_VB cell_NN phenotype_NN and_CC there_EX was_VBD no_DT evidence_NN for_IN autoregulation_NN of_IN SCL_NN transcription_NN ._.
In_IN contrast_NN ,_, interleukin-1beta-converting_JJ enzyme_NN family_NN protease_NN inhibitors_NNS Ac-DEVD-CHO_NN and_CC CrmA_NN blocked_VBD Fas-mediated_JJ apoptosis_NN ._.
An_DT acquired_JJ form_NN of_IN peripheral_JJ resistance_NN to_TO glucocorticoids_NNS was_VBD suspected_VBN ._.
Conversely_RB ,_, diurnal_JJ rhythmicity_NN persisted_VBD in_IN apoplexy_NN patients_NNS lesions_NNS were_VBD in_IN the_DT cerebral_JJ cortex_NN ._.
This_DT lack_NN of_IN sensitivity_NN is_VBZ unexplained_JJ but_CC is_VBZ not_RB attributable_JJ to_TO abnormalities_NNS of_IN cellular_JJ glucocorticoid_NN receptors_NNS ._.
In_IN particular_JJ ,_, Tax_NN is_VBZ capable_JJ of_IN modulating_VBG the_DT expression_NN or_CC activity_NN of_IN various_JJ host_NN transcription_NN factors_NNS ,_, including_VBG members_NNS of_IN the_DT NF-kappa_NN and_CC families_NNS ,_, as_RB well_RB as_IN the_DT cellular_JJ factors_NNS HEB-1_NN and_CC p67SRF_NN ._.
There_EX is_VBZ little_JJ information_NN available_JJ on_IN the_DT response_NN of_IN NF_NN kappa_NN B_NN to_TO cytokines_NNS in_IN normal_JJ human_JJ monocytes_NNS ._.
Overexpression_NN of_IN SRF_NN in_IN B_NN cells_NNS causes_VBZ the_DT IL-2R_NN enhancer_NN to_TO function_VB as_RB well_RB as_IN it_PRP does_VBZ in_IN T_NN cells_NNS ,_, suggesting_VBG that_IN the_DT high_JJ level_NN of_IN SRF_NN binding_NN in_IN T_NN cells_NNS is_VBZ functionally_RB important_JJ ._.
Furthermore_RB ,_, the_DT most_RBS important_JJ trans-acting_JJ factors_NNS of_IN T_NN and_CC B_NN lymphocytes_NNS e.g._FW NF-kB_NN ,_, NF-AT_NN and_CC STAT_NN families_NNS and_CC functional_JJ importance_NN are_VBP described_VBN ._.
The_DT previously_RB defined_VBN minimal_JJ enhancer_NN containing_VBG the_DT muA_NN ,_, muE3_NN ,_, and_CC muB_NN sites_NNS is_VBZ transactivated_VBN by_IN a_DT combination_NN of_IN the_DT ETS-domain_NN proteins_NNS PU.1_NN and_CC Ets-1_NN in_IN nonlymphoid_JJ cells_NNS ._.
The_DT transcriptionally_RB regulatory_JJ regions_NNS of_IN the_DT lymphomagenic_JJ Akv_NN and_CC SL3-3_NN murine_JJ leukemia_NN retroviruses_NNS MLVs_NNS contain_VBP two_CD types_NNS of_IN E-box_NN consensus_NN motifs_NNS ,_, CAGATG_NN ._.
Moreover_RB ,_, M-CSF-induced_JJ expression_NN of_IN the_DT fos-related_JJ gene_NN ,_, fra-1_NN ,_, was_VBD delayed_VBN compared_VBN to_TO that_DT for_IN both_DT c-fos_NN and_CC fos-B_NN ._.
There_EX is_VBZ increasing_VBG evidence_NN that_IN lipoproteins_NNS of_IN Treponema_FW pallidum_FW and_CC Borrelia_FW burgdorferi_FW are_VBP key_JJ inflammatory_JJ mediators_NNS during_IN syphilis_NN and_CC Lyme_NN disease_NN ._.
The_DT Ro_NN in_IN the_DT CS_JJ group_NN was_VBD 3,605_CD 984_CD binding_VBG sites_NNS per_IN nucleus_NN mean_NN SEM_NN ,_, n_NN 6_CD and_CC 4,757_CD 692_CD binding_VBG sites_NNS per_IN nucleus_NN mean_NN SEM_NN ,_, n_NN 6_CD in_IN the_DT CR_JJ group_NN p_NN 0.23_CD ._.
Here_RB we_PRP demonstrate_VBP that_IN the_DT human_JJ GM-CSF_NN promoter_NN and_CC enhancer_NN also_RB encompass_VBP binding_VBG sites_NNS for_IN core-binding_JJ factor_NN CBF_NN ._.
We_PRP show_VBP that_IN a_DT cellular_JJ reducing_NN catalyst_NN thioredoxin_NN Trx_NN plays_VBZ a_DT major_JJ role_NN in_IN activation_NN of_IN the_DT DNA_NN binding_NN of_IN NF_NN kappa_NN B_NN in_FW vitro_FW and_CC stimulation_NN of_IN transcription_NN from_IN the_DT NF_NN kappa_NN B-dependent_JJ gene_NN expression_NN ._.
NP_NN and_CC other_JJ thiol_JJ compounds_NNS also_RB blocked_VBD the_DT activation_NN of_IN NF-kappa_NN B_NN by_IN cycloheximide_NN ,_, double-stranded_JJ RNA_NN ,_, calcium_NN ionophore_NN ,_, TNF-alpha_NN ,_, active_JJ phorbol_NN ester_NN ,_, interleukin-1_NN ,_, lipopolysaccharide_NN and_CC lectin_NN ._.
Here_RB we_PRP show_VBP that_IN when_WRB added_VBN exogenously_RB to_TO cells_NNS ,_, Hsp70_NN is_VBZ readily_RB imported_VBN into_IN both_CC cytoplasmic_JJ and_CC nuclear_JJ compartments_NNS in_IN a_DT cell-type-specific_JJ fashion_NN ._.
Further_JJ evidence_NN suggests_VBZ that_IN Nef_NN inhibits_VBZ NF-kappa_NN B_NN induction_NN by_IN interfering_VBG with_IN a_DT signal_NN derived_VBN from_IN the_DT T-cell_NN receptor_NN complex_NN ._.